Apollomics (APLM) Current Deferred Tax Assets (2022 - 2024)
Apollomics (APLM) posted quarterly Current Deferred Tax Assets of $2.9 million for Q4 2024, down 89.12% year-on-year from $26.4 million in Q1 2024, and down 81.81% on a QoQ basis from $15.8 million in Q2 2024.
Apollomics (APLM) Current Deferred Tax Assets (2022 - 2024) Analysis & Trends
Apollomics (APLM) has reported Current Deferred Tax Assets for 3 consecutive years, with $2.9 million the latest figure, recorded in Q4 2024.
- Quarterly Current Deferred Tax Assets fell 89.12% year-over-year to $2.9 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $2.9 million (down 89.12% YoY) and the FY2024 annual result came in at $2.9 million, down 89.12% from the prior year.
- Current Deferred Tax Assets slipped to $2.9 million in Q4 2024 per APLM's latest filing, from $15.8 million in the prior quarter.
- Over the last five years, Current Deferred Tax Assets for APLM reached as high as $43.4 million in Q4 2022 and fell as low as $2.9 million in Q4 2024.
- A 3-year average of $25.9 million and a median of $26.4 million in 2023 frame the typical range for Current Deferred Tax Assets.
- Annual changes were most pronounced in 2023 — Current Deferred Tax Assets sank 39.29% — and 2024, when it tumbled 89.12%.
- Year by year, Current Deferred Tax Assets stood at $43.4 million in 2022, then plunged by 39.29% to $26.4 million in 2023, then slumped by 89.12% to $2.9 million in 2024.
- According to Business Quant data, Current Deferred Tax Assets over the past three periods registered $2.9 million, $15.8 million, and $26.4 million for Q4 2024, Q2 2024, and Q4 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Apollomics | 2.66 Bn | 2.66 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 2.87 Mn |
| Dec 31, 2024 | 2.87 Mn |
| Jun 30, 2024 | 15.76 Mn |
| Jun 30, 2024 | 15.76 Mn |
| Dec 31, 2023 | 26.37 Mn |
| Dec 31, 2023 | 26.37 Mn |
| Jun 30, 2023 | 41.24 Mn |
| Jun 30, 2023 | 41.24 Mn |
| Dec 31, 2022 | 43.43 Mn |
| Dec 31, 2022 | 43.43 Mn |